Le Lézard
Classified in: Health, Science and technology
Subjects: TDS, FDA

DiA Granted FDA Clearance for its Cardiac Ultrasound AI Auto Views Selection


BE'ER SHEVA, Israel, Oct. 29, 2020 /PRNewswire/ -- DiA Imaging Analysis announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the commercial use of LVivo Seamless for automatic view selection. LVivo Seamless algorithms automatically run "behind the scenes" to select the optimal cardiac ultrasound views out of 40-60 views in standard echocardiogram exams. Finding the right views in each echo exam is cumbersome and time-consuming. The ability to auto-select views is a breakthrough in AI implementation and the value that it brings to the echocardiography workflow.

"LVivo software operates without human touch, and adds great value," says Dr. Steve Feinstein, professor of cardiology at Rush University Medical Center. "These rapid, reliable and accurate serial views selections and measurements enable us to get second opinions and access anytime and anywhere."

The cleared LVivo Seamless solution integrates with DiA's other LVivo cardiac auto analysis toolbox products such as LVivo EF, an automated calculation of ejection fraction (EF) calculation, which is a main indicator of global heart function.

This enables clinicians to automatically obtain, for each echo-lab cardiac exam, optimal views and automated measurements in a fast, accurate and objective way.

All of DiA's ultrasound AI solutions are cross-platform and vendor-neutral; therefore, they can run on images acquired from any ultrasound device and can easily operate with any radiology image viewer.

"LVivo Seamless joins DiA's existing other solutions, to help reducing the variability associated with manually selecting views and visually analyzing cardiac ultrasound images," said Hila Goldman-Aslan, DiA's CEO and Co-Founder.

LVivo Toolbox provides both the clinical and financial value that stakeholders in the echo lab are looking for.

About DiA Imaging Analysis

DiA Imaging Analysis is a leading provider of AI-powered ultrasound analysis solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. The company's LVivo product line for cardiac and abdominal auto analysis allow clinicians with various levels of ultrasound experience to use and analyze ultrasound images on their ultrasound devices or healthcare IT systems with increased speed, efficiency and accuracy. DiA currently serves thousands of end users worldwide. 

For additional information, please visit http://www.dia-analysis.com.

DiA will demonstrate its full LVivo Toolbox suite at its virtual booth during the upcoming Radiological Society of North America (RSNA) 2020 virtual meeting.

For further information, please contact
Edith Schlanger
Marketing Manager
DiA Imaging Analysis 
edith@dia-analysis.com

 

SOURCE DiA Imaging Analysis


These press releases may also interest you

4 déc 2020
Today, Biocom California, the association representing the California life science industry, joined the Biotechnology Innovation Organization (BIO) and the California Life Sciences Association (CLSA) in filing a challenge against the Department of...

4 déc 2020
Today, the U.S. Food and Drug Administration authorized the first diagnostic test for at home collection of patient samples to detect both COVID-19 and influenza A and B (flu). The FDA authorized Quest Diagnostics RC COVID-19 +Flu RT-PCR Test for...

4 déc 2020
AB Staffing Solutions, LLC ("AB Staffing") provides notice of a recent incident that may impact the security of information related to current and former professionals placed by AB Staffing.  The confidentiality, privacy, and security of information...

4 déc 2020
CooTek (Cayman) Inc. ("CooTek" or the "Company"), a fast-growing global mobile internet company, today announced that it will report its unaudited financial results for the third quarter 2020 ended September 30, 2020, before the open of U.S. markets...

4 déc 2020
Regardless of their physical size, location or specimen load, Microbiology laboratories can significantly boost their efficiencies ? and subsequently cut labor costs ? by replacing manual processes with full automation, according to a new study...

4 déc 2020
The gamification market is expected to grow by USD 17.56 billion, progressing at a CAGR of over 27% during the forecast period. For a More Detailed Analysis, Get a Free Sample Report Delivered Instantly The increasing adoption of gamification in...



News published on 29 october 2020 at 09:30 and distributed by: